Literature DB >> 15353501

Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.

Edward P Gerstenfeld1, David J Callans, Sanjay Dixit, Andrea M Russo, Hemal Nayak, David Lin, Ward Pulliam, Sultan Siddique, Francis E Marchlinski.   

Abstract

BACKGROUND: A proarrhythmic consequence of pulmonary vein (PV) isolation can be a recurrent organized left atrial (LA) tachycardia after ablation. This arrhythmia is frequently referred to as "left atrial flutter," but the mechanism and best ablation strategy have not been determined. METHODS AND
RESULTS: Isolation of arrhythmogenic PVs was initially performed by segmental ostial PV ablation guided by a circular mapping catheter in 341 patients. Patients whose predominant recurrent arrhythmia was a persistent organized tachycardia returned for mapping and ablation. Recurrent organized LA tachycardias (cycle length 253+/-33 ms, range 213 to 328 ms) occurred in 10 (2.9%) of 341 patients (age 59+/-9 years, 1 woman). Mapping was consistent with a focal origin in 8 patients and with macroreentry in 1 patient and was unclear in 1 patient owing to degeneration to atrial fibrillation. Focal tachycardias originated from reconnected segments of prior isolated PVs (6 patients), the posterior LA (1 patient), or the superior septum (1 patient). Focal atrial tachycardias were ablated with point lesions that targeted the earliest activation. All reconnected PVs were also reisolated. Reentrant LA flutter occurred around the left PVs in 1 patient. After 6.7+/-2.3 months of follow-up, 9 (90%) of 10 patients were arrhythmia free (4 of whom were taking antiarrhythmic drug therapy), and one was having recurrent atrial fibrillation.
CONCLUSIONS: Recurrent organized LA tachycardia after PV isolation is uncommon and typically has a focal origin from reconnected PV ostia. Reisolation of the PV and ablation of non-PV foci are sufficient to treat this proarrhythmia. Linear lesions are only required when a macroreentrant mechanism is present.

Entities:  

Mesh:

Year:  2004        PMID: 15353501     DOI: 10.1161/01.CIR.0000141369.50476.D3

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  59 in total

1.  Pulmonary venous isolation versus additional substrate modification as treatment for paroxysmal atrial fibrillation.

Authors:  Andrew Robertson Gavin; Cameron B Singleton; John Bowyer; Andrew D McGavigan
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Catheter ablation of permanent atrial fibrillation: medium term results.

Authors:  M J Earley; D J R Abrams; A D Staniforth; S C Sporton; R J Schilling
Journal:  Heart       Date:  2005-08-23       Impact factor: 5.994

3.  Catheter ablation of atrial fibrillation: ongoing atrial fibrillation inside a single pulmonary vein after successful electrical disconnection and restoration of sinus rhythm in both atria.

Authors:  K Kettering; G F Greil; M Busch; S Miller; L Sieverding; J Schreieck
Journal:  Clin Res Cardiol       Date:  2006-09-28       Impact factor: 5.460

Review 4.  [Current strategies in the treatment of atrial fibrillation].

Authors:  Imke Drewitz; Thomas Rostock; Boris Hoffmann; Daniel Steven; Helge Servatius; Thomas Meinertz; Stephan Willems
Journal:  Med Klin (Munich)       Date:  2008-11-15

Review 5.  Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.

Authors:  Gustavo R Goldenberg; Daniel Burd; Piotr Lodzinski; Giuseppe Stabile; Jacob A Udell; David Newman; Mohammed Shurrab; Eugene Crystal
Journal:  J Interv Card Electrophysiol       Date:  2016-06-29       Impact factor: 1.900

6.  Feasibility of using patient-specific models and the "minimum cut" algorithm to predict optimal ablation targets for left atrial flutter.

Authors:  Sohail Zahid; Kaitlyn N Whyte; Erica L Schwarz; Robert C Blake; Patrick M Boyle; Jonathan Chrispin; Adityo Prakosa; Esra G Ipek; Farhad Pashakhanloo; Henry R Halperin; Hugh Calkins; Ronald D Berger; Saman Nazarian; Natalia A Trayanova
Journal:  Heart Rhythm       Date:  2016-04-19       Impact factor: 6.343

Review 7.  Evidence-based approach to ablating atrial fibrillation.

Authors:  Takumi Yamada; G Neal Kay
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

8.  Catheter ablation for atrial fibrillation in patients with the Marfan and Marfan-like syndromes.

Authors:  T Jared Bunch; Heidi M Connolly; Samuel J Asirvatham; Peter A Brady; Bernard J Gersh; Thomas M Munger; Win-Kuang Shen; Kristi H Monahan; Douglas L Packer
Journal:  J Interv Card Electrophysiol       Date:  2007-10-20       Impact factor: 1.900

9.  Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn?

Authors:  Ashok J Shah; Amir Jadidi; Xingpeng Liu; Shinsuke Miyazaki; Andrei Forclaz; Isabelle Nault; Lena Rivard; Nick Linton; Olivier Xhaet; Nicolas Derval; Frederic Sacher; Pierre Bordachar; Philippe Ritter; Meleze Hocini; Pierre Jais; Michel Haissaguerre
Journal:  Cardiol Res Pract       Date:  2010-04-07       Impact factor: 1.866

10.  Radiofrequency ablation of coronary sinus-dependent atrial flutter guided by fractionated mid-diastolic coronary sinus potentials.

Authors:  Joelci Tonet; Antonio De Sisti; Walid Amara; Robert Frank; Françoise Hidden-Lucet
Journal:  J Interv Card Electrophysiol       Date:  2010-09-04       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.